Devasena Anantharaman

3.1k total citations · 1 hit paper
31 papers, 814 citations indexed

About

Devasena Anantharaman is a scholar working on Otorhinolaryngology, Surgery and Epidemiology. According to data from OpenAlex, Devasena Anantharaman has authored 31 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Otorhinolaryngology, 9 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Devasena Anantharaman's work include Head and Neck Cancer Studies (12 papers), Leprosy Research and Treatment (6 papers) and Hepatitis B Virus Studies (5 papers). Devasena Anantharaman is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Leprosy Research and Treatment (6 papers) and Hepatitis B Virus Studies (5 papers). Devasena Anantharaman collaborates with scholars based in France, India and United States. Devasena Anantharaman's co-authors include Paul Brennan, Manoj B. Mahimkar, Behnoush Abedi‐Ardekani, José P. Zevallos, Andrew F. Olshan, Mark C. Weissler, Sadhana Kannan, Angela L. Mazul, Rajani A. Bhisey and D. Neil Hayes and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Devasena Anantharaman

30 papers receiving 790 citations

Hit Papers

Long‐term Survival in Head and Neck Cancer: Impact of Sit... 2019 2026 2021 2023 2019 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devasena Anantharaman France 15 300 295 180 176 162 31 814
Ekkasit Tharavichitkul Thailand 15 154 0.5× 146 0.5× 91 0.5× 219 1.2× 312 1.9× 69 820
Laia Alemany Spain 13 412 1.4× 132 0.4× 89 0.5× 211 1.2× 232 1.4× 35 697
M. Mena Spain 15 740 2.5× 271 0.9× 191 1.1× 366 2.1× 371 2.3× 31 1.2k
Yin‐Chu Chien Taiwan 8 141 0.5× 76 0.3× 73 0.4× 363 2.1× 122 0.8× 10 726
Sandra P. Gibson United States 13 129 0.4× 147 0.5× 91 0.5× 589 3.3× 93 0.6× 27 996
Anupam Sarma India 12 86 0.3× 206 0.7× 119 0.7× 152 0.9× 67 0.4× 61 567
Jon Mork Norway 10 768 2.6× 204 0.7× 198 1.1× 397 2.3× 423 2.6× 17 1.2k
Siddharth Sheth United States 16 223 0.7× 123 0.4× 61 0.3× 260 1.5× 133 0.8× 60 607
Jos Nauta Netherlands 8 268 0.9× 81 0.3× 33 0.2× 232 1.3× 183 1.1× 16 566
Brittany Holmes United States 14 98 0.3× 109 0.4× 46 0.3× 126 0.7× 232 1.4× 24 594

Countries citing papers authored by Devasena Anantharaman

Since Specialization
Citations

This map shows the geographic impact of Devasena Anantharaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devasena Anantharaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devasena Anantharaman more than expected).

Fields of papers citing papers by Devasena Anantharaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devasena Anantharaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devasena Anantharaman. The network helps show where Devasena Anantharaman may publish in the future.

Co-authorship network of co-authors of Devasena Anantharaman

This figure shows the co-authorship network connecting the top 25 collaborators of Devasena Anantharaman. A scholar is included among the top collaborators of Devasena Anantharaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devasena Anantharaman. Devasena Anantharaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
George, Preethi Sara, et al.. (2024). Frequency and clinical significance of human papilloma virus in oral cancer - A study from Kerala. Indian Journal of Cancer. 61(4). 722–727.
3.
Anantharaman, Devasena, et al.. (2023). Targeting acid ceramidase enhances antitumor immune response in colorectal cancer. Journal of Advanced Research. 65. 73–87. 12 indexed citations
4.
Gheit, Tarik, Richard Muwonge, Eric Lucas, et al.. (2022). Impact of HPV vaccination on HPV-related oral infections. Oral Oncology. 136. 106244–106244. 11 indexed citations
5.
Mariz, Filipe Colaço, Noemi Bender, Devasena Anantharaman, et al.. (2020). Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines. npj Vaccines. 5(1). 14–14. 34 indexed citations
6.
Sheth, Siddharth, Douglas Farquhar, Nicholas R. Lenze, et al.. (2020). Decreased overall survival in black patients with HPV-associated oropharyngeal cancer. American Journal of Otolaryngology. 42(1). 102780–102780. 15 indexed citations
7.
Farquhar, Douglas, Maheer M. Masood, Nicholas R. Lenze, et al.. (2020). Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer. Oral Oncology. 108. 104800–104800. 3 indexed citations
8.
Bradshaw, Patrick T., Mark C. Weissler, José P. Zevallos, et al.. (2018). Interaction between known risk factors for head and neck cancer and socioeconomic status: the Carolina Head and Neck Cancer Study. Cancer Causes & Control. 29(9). 863–873. 42 indexed citations
9.
Pérdomo, Sandra, Devasena Anantharaman, Matthieu Foll, et al.. (2018). Genomic analysis of head and neck cancer cases from two high incidence regions. PLoS ONE. 13(1). e0191701–e0191701. 17 indexed citations
10.
Mena, M., Belén Lloveras, Sara Tous, et al.. (2017). Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study. PLoS ONE. 12(10). e0184520–e0184520. 11 indexed citations
11.
Mazul, Angela L., James M. Taylor, Paul Brennan, et al.. (2016). Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma. Oral Oncology. 61. 98–103. 40 indexed citations
12.
Zevallos, José P., Angela L. Mazul, Mark C. Weissler, et al.. (2016). Previous tonsillectomy modifies odds of tonsil and base of tongue cancer. British Journal of Cancer. 114(7). 832–838. 18 indexed citations
13.
Anantharaman, Devasena, Amélie Chabrier, Valérie Gaborieau, et al.. (2014). Genetic Variants in Nicotine Addiction and Alcohol Metabolism Genes, Oral Cancer Risk and the Propensity to Smoke and Drink Alcohol: A Replication Study in India. PLoS ONE. 9(2). e88240–e88240. 28 indexed citations
14.
Mahimkar, Manoj B., et al.. (2011). Polymorphisms in GSTM1 and XPD genes predict clinical outcome in advanced oral cancer patients treated with postoperative radiotherapy. Molecular Carcinogenesis. 51(S1). E94–103. 24 indexed citations
15.
Anantharaman, Devasena, et al.. (2011). Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncology. 47(9). 866–872. 40 indexed citations
16.
Anantharaman, Devasena, Michael Pawlita, Tim Waterboer, et al.. (2011). Abstract 1890: Human papillomavirus serology and the risk of lung cancer. Cancer Research. 71(8_Supplement). 1890–1890. 1 indexed citations
17.
Anantharaman, Devasena, et al.. (2007). Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. 28(7). 1455–1462. 131 indexed citations
18.
Gupte, M D, et al.. (1999). Comparative leprosy vaccine trial in south India.. PubMed. 70(4). 369–88. 41 indexed citations
19.
Anantharaman, Devasena, et al.. (1998). Underutilization of the available services by the needy disabled leprosy patients in Government Leprosy Control Unit Puttoor, Chittoor district, Andhra Pradesh, South India.. PubMed. 70 Suppl. 47S–61S. 5 indexed citations
20.
Gupte, M D, et al.. (1990). Experiences with Mycobacterium lepraesoluble antigens in a leprosyendemic population. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026